In addition, there were several studies on HSCT that showed that CTLA4 SNPs have been associated with differences in relapse free survival (RFS), overall survival (OS), and GVHD, but there were discordant results between these investigators [18,19,20,21,22]. This evidence concerns the gene CTLA4 and graft versus host disease.